Literature DB >> 2429980

The transfer of antigen-specific humoral immunity from marrow donors to marrow recipients.

L G Lum, M C Seigneuret, R Storb.   

Abstract

This study shows that specific humoral immunity could be transferred from marrow donors to marrow recipients. Peripheral blood lymphocytes from long-term human marrow recipients produced IgG anti-tetanus toxoid antibody after in vitro tetanus toxoid stimulation. Antitetanus toxoid antibody biosynthesis was induced using a new tetanus toxoid-specific system employing high lymphocyte numbers, many replicate microcultures, and antigen washout. Anti-tetanus toxoid antibody in 12-day culture supernatants was detected using an enzyme-linked immunosorbent assay. Of 14 marrow recipients, 6 (5 with and 1 without chronic graft-vs-host disease) had lymphocytes that produced anti-tetanus toxoid antibody. Culturing additional numbers of marrow recipient lymphocytes increased in vitro biosynthesis of anti-tetanus toxoid antibody. The presence of circulating serum antibodies to tetanus toxoid and the production of specific anti-tetanus toxoid antibody by peripheral blood lymphocytes from marrow recipients show that engrafted donor lymphocytes can produce in vitro specific antibodies to recall antigens without postgrafting reimmunization.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2429980     DOI: 10.1007/bf00915378

Source DB:  PubMed          Journal:  J Clin Immunol        ISSN: 0271-9142            Impact factor:   8.317


  28 in total

1.  The regulation of Ig synthesis after marrow transplantation. IV. T4 and T8 subset function in patients with chronic graft-vs-host disease.

Authors:  L G Lum; N Orcutt-Thordarson; M C Seigneuret; R Storb
Journal:  J Immunol       Date:  1982-07       Impact factor: 5.422

2.  Marrow transplantation for acute nonlymphoblastic leukemic in first remission using fractionated or single-dose irradiation.

Authors:  E D Thomas; R A Clift; J Hersman; J E Sanders; P Stewart; C D Buckner; A Fefer; R McGuffin; J W Smith; R Storb
Journal:  Int J Radiat Oncol Biol Phys       Date:  1982-05       Impact factor: 7.038

3.  Allogeneic marrow grafting for treatment of aplastic anemia.

Authors:  R Storb; E D Thomas; C D Buckner; R A Clift; F L Johnson; A Fefer; H Glucksberg; E R Giblett; K G Lerner; P Neiman
Journal:  Blood       Date:  1974-02       Impact factor: 22.113

4.  The induction and suppression of in vitro IgG anti-tetanus toxoid antibody synthesis by human lymphocytes stimulated with tetanus toxoid in the absence of in vivo booster immunizations.

Authors:  L G Lum; N J Culbertson
Journal:  J Immunol       Date:  1985-07       Impact factor: 5.422

5.  One hundred patients with acute leukemia treated by chemotherapy, total body irradiation, and allogeneic marrow transplantation.

Authors:  E D Thomas; C D Buckner; M Banaji; R A Clift; A Fefer; N Flournoy; B W Goodell; R O Hickman; K G Lerner; P E Neiman; G E Sale; J E Sanders; J Singer; M Stevens; R Storb; P L Weiden
Journal:  Blood       Date:  1977-04       Impact factor: 22.113

6.  The detection of specific antibody formation to recall antigens after human bone marrow transplantation.

Authors:  L G Lum; N A Munn; M S Schanfield; R Storb
Journal:  Blood       Date:  1986-03       Impact factor: 22.113

7.  Pneumococcal infections after human bone-marrow transplantation.

Authors:  D J Winston; G Schiffman; D C Wang; S A Feig; C H Lin; E L Marso; W G Ho; L S Young; R P Gale
Journal:  Ann Intern Med       Date:  1979-12       Impact factor: 25.391

8.  Abnormal humoral immune responses in peripheral blood lymphocyte cultures of bone marrow transplant recipients.

Authors:  S G Pahwa; R N Pahwa; W Friedrich; R J O'Reilly; R A Good
Journal:  Proc Natl Acad Sci U S A       Date:  1982-04       Impact factor: 11.205

9.  Immunoglobulin production after marrow transplantation. III. The functional heterogeneity of FC-IgG receptor positive and negative T cell subpopulations.

Authors:  L G Lum; M C Seigneuret; N Orcutt-Thordarson; R C Ostenson; R Storb
Journal:  Clin Exp Immunol       Date:  1982-06       Impact factor: 4.330

10.  In vitro regulation of immunoglobulin synthesis after marrow transplantation. I. T-cell and B-cell deficiencies in patients with and without chronic graft-versus-host disease.

Authors:  L G Lum; M C Seigneuret; R F Storb; R P Witherspoon; E D Thomas
Journal:  Blood       Date:  1981-09       Impact factor: 22.113

View more
  5 in total

1.  Targeting human B-cell malignancies through Ig light chain-specific cytotoxic T lymphocytes.

Authors:  Jinsheng Weng; Soung-Chul Cha; Satoko Matsueda; Gheath Alatrash; Michael S Popescu; Qing Yi; Jeffrey J Molldrem; Michael Wang; Sattva S Neelapu; Larry W Kwak
Journal:  Clin Cancer Res       Date:  2011-08-03       Impact factor: 12.531

2.  IgG anti-tetanus toxoid antibody synthesis by human bone marrow. I. Two distinct populations of marrow B cells and functional differences between marrow and peripheral blood B cells.

Authors:  L G Lum; E Burns; M M Janson; P J Martin; B R Giddings; M C Seigneuret; J E Noges; S C Galoforo
Journal:  J Clin Immunol       Date:  1990-09       Impact factor: 8.317

3.  A role for mature B cells in bone marrow transplantation.

Authors:  T Yoshio; K Saito; F L Adler; L T Adler
Journal:  Immunology       Date:  1988-05       Impact factor: 7.397

4.  Neoantigen and tumor antigen-specific immunity transferred from immunized donors is detectable early after allogeneic transplantation in myeloma patients.

Authors:  M Foglietta; S S Neelapu; L W Kwak; Y Jiang; D Nattamai; S-T Lee; D H Fowler; C Sportes; R E Gress; S M Steinberg; L M Vence; L Radvanyi; K C Dwyer; M H Qazilbash; R N K Bryant; M R Bishop
Journal:  Bone Marrow Transplant       Date:  2012-07-09       Impact factor: 5.483

5.  Immune T cells can transfer and boost anti-breast cancer immunity.

Authors:  Archana Thakur; Ritesh Rathore; Sri Vidya Kondadasula; Joseph P Uberti; Voravit Ratanatharathorn; Lawrence G Lum
Journal:  Oncoimmunology       Date:  2018-08-27       Impact factor: 8.110

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.